{"anticipatedPostingDate":"2028-03","denomUnitsSelected":"Participants","description":"PFS was defined as time from randomization until disease progression (PD) or death from any cause, whichever occurs first for all participants. Progression was based on investigator assessment of disease response per Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1.\n\nPD: radiologic detection of ≥ 20% increase in the sum of diameters of target lesions and ≥ 5 mm absolute increase, or unequivocal progression of non-index lesions, or the presence of new lesions. 95% CIs were calculated using the Brookmeyer and Crowley method.","reportingStatus":"NOT_POSTED","timeFrame":"Up to approximately 4 years","title":"Progression Free Survival (PFS)","type":"SECONDARY"}